International Journal of Rheumatology / 2010 / Article / Fig 1

Review Article

Interleukin-6 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension

Figure 1

Chest X-ray before tocilizumab and after 6-month treatment with tocilizumab.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.